Articles from The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Fluence Energy, Inc. (“Fluence” or the “Company”) (NASDAQFLNC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Viatris Inc. (“Viatris” or the “Company”) (NASDAQVTRS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQDMRC) securities between May 2, 2024 and February 26, 2025, inclusive (the “Class Period”). Digimarc investors have until May 9, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased The Trade Desk (“Trade Desk” or the “Company”) (NASDAQTTD) Class A common stock or call options, or sold Trade Desk put options between May 9, 2024 and February 12, 2025. Trade Desk investors have until April 21, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces an investigation of RH (“RH” or the “Company”) (NYSERH) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Daktronics, Inc. (“Daktronics” or the “Company”) (NASDAQDAKT) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of e.l.f. Beauty, Inc. (“Elf” or the “Company”) (NYSEELF) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Mayer v. Digimarc Corporation, et al., Case No. 1:25-cv-01963, on behalf of persons and entities that purchased or otherwise acquired Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQDMRC) securities between May 2, 2024 and February 26, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQMRVI) securities between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”). Maravai investors have until May 4, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Ready Capital Corporation (“Ready Capital” or the “Company”) (NYSERC) common stock between November 7, 2024 and March 2, 2025, inclusive (the “Class Period”). Ready Capital investors have until May 5, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz reminds investors of the upcoming March 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQBIOA) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s September 2024 initial public offering (the “IPO” or the “Offering”).

The Law Offices of Frank R. Cruz continues its investigation of Digimarc Corporation (“Digimarc” or the “Company”) (NASDAQDMRC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz reminds investors of the upcoming March 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQREGN) securities between November 2, 2023 and October 30, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz continues its investigation of Flywire Corporation (“Flywire” or the “Company”) (NASDAQFLYW) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz continues its investigation of enCore Energy Corp. (“enCore” or the “Company”) (NASDAQEU) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQTBBK) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Skyworks Solutions, Inc. (“Skyworks” or the “Company”) (NASDAQSWKS) securities between July 30, 2024 to February 5, 2025, inclusive (the “Class Period”). Skyworks investors have until May 5, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz continues its investigation of Encore Capital Group, Inc. (“Encore Capital” or the “Company”) (NASDAQECPG) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz continues its investigation of Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSECIVI) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of California, captioned Nelson v. Maravai LifeSciences Holdings, Inc., et al., Case No. 25-cv-00499, on behalf of persons and entities that purchased or otherwise acquired Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQMRVI) securities between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

The Law Offices of Frank R. Cruz announces an investigation of Encore Capital Group, Inc. (“Encore Capital” or the “Company”) (NASDAQECPG) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of enCore Energy Corp. (“enCore” or the “Company”) (NASDAQEU) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Ready Capital Corporation (“Ready Capital” or the “Company”) (NYSERC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz reminds investors of the upcoming March 4, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQRVNC) securities between February 29, 2024 and December 6, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQQUBT) securities between March 30, 2020 and January 15, 2025, inclusive (the “Class Period”). QCI investors have until April 28, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQRKLB) securities between November 12, 2024 and February 25, 2025, inclusive (the “Class Period”). Rocket Lab investors have until April 28, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces an investigation of Ibotta, Inc. (“Ibotta” or the “Company”) (NYSEIBTA) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSECIVI) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Flywire Corporation (“Flywire” or the “Company”) (NASDAQFLYW) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQAPP) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQRKLB) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQMRVI) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased The Trade Desk, Inc. (“Trade Desk” or the “Company”) (NASDAQTTD) Class A common stock between May 9, 2024 and February 12, 2025, inclusive (the “Class Period”). Trade Desk investors have until April 21, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Semtech Corporation (“Semtech” or the “Company”) (NASDAQSMTC) securities between August 27, 2024 and February 7, 2025, inclusive (the “Class Period”). Semtech investors have until April 22, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 25, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQNXT) common stock between February 1, 2024 and August 1, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Kleovoulos v. Semtech Corporation, et al., Case No. 25-cv-1474, on behalf of persons and entities that purchased or otherwise acquired Semtech Corporation (“Semtech” or the “Company”) (NASDAQSMTC) securities between August 27, 2024 and February 7, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Venture Global, Inc. (“Venture” or the “Company”) (NYSEVG) securities pursuant and/or traceable to the Company’s January 2025 initial public offering (“IPO”). Venture investors have until April 18, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQALAR) securities between March 14, 2024 and August 26, 2024, inclusive (the “Class Period”). Alarum investors have until April 15, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces an investigation of Merck & Co (“Merck” or the “Company”) (NYSEMRK) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Constellation Brands, Inc. (“Constellation” or the “Company”) (NYSESTZ) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Parsons Corporation (“Parsons” or the “Company”) (NYSEPSN) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 21, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQAZN) securities between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces an investigation of Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQALAR) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Venture Global, Inc. (“Venture” or the “Company”) (NYSEVG) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Elastic N.V. (“Elastic” or the “Company”) (NYSEESTC) securities between May 31, 2024 and August 29, 2024, inclusive (the “Class Period”). Elastic investors have until April 14, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Joint Stock Company Kaspi.kz (“Kaspi” or the “Company”) (NASDAQKSPI) securities between January 19, 2024 and September 19, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces an investigation of Everus Construction Group, Inc. (“Everus” or the “Company”) (NYSEECG) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of ePlus inc. (“ePlus” or the “Company”) (NASDAQPLUS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of MRC Global Inc. (“MRC” or the “Company”) (NYSEMRC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Gencor Industries, Inc. (“Gencor” or the “Company”) (NYSE American: GENC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Skyworks Solutions, Inc. (“Skyworks” or the “Company”) (NASDAQSWKS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 14, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired MGP Ingredients, Inc. (“MGPI” or the “Company”) (NASDAQMGPI) common stock between May 4, 2023 through October 30, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces an investigation of Semtech Corporation (“Semtech” or the “Company”) (NASDAQSMTC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased GSK plc. (“GSK” or the “Company”) (NYSEGSK) American Depositary Receipts (“ADRs”) between February 5, 2020, and August 14, 2022, inclusive (the “Class Period”). GSK investors have until April 7, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 7, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ) securities between May 7, 2024 and November 4, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces an investigation of Monolithic Power Systems Inc. (“Monolithic” or the “Company”) (NASDAQMPWR) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of FMC Corporation (“FMC” or the “Company”) (NYSEFMC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of GSK plc. (“GSK” or the “Company”) (NYSEGSK) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 7, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQKYTX) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s February 2024 initial public offering (the “IPO” or the “Offering”).

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Sun Communities, Inc. (“Sun Communities” or the “Company”) (NYSESUI) securities between February 28, 2019 and September 24, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces an investigation of Celanese Corporation (“Celanese” or the “Company”) (NYSECE) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased ModivCare, Inc. (“ModivCare” or the “Company”) (NASDAQMODV) securities between November 3, 2022 and September 15, 2024, inclusive (the “Class Period”). ModivCare investors have until March 31, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) common stock between November 3, 2022 and October 28, 2024, inclusive (the “Class Period”). Crocs investors have until March 24, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased TELUS International (Cda) Inc. (“Telus International” or the “Company”) (NYSETIXT) securities between February 16, 2023 and August 1, 2024, inclusive (the “Class Period”). Telus International investors have until March 31, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”). IAS investors have until March 31, 2025 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 4, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired DMC Global Inc. (“DMC” or the “Company”) (NASDAQBOOM) securities between January 29, 2024 and November 4, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 3, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces an investigation of ModivCare, Inc. (“ModivCare” or the “Company”) (NASDAQMODV) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz reminds investors of the upcoming January 31, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSECUBI) securities between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 3, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQAEHR) securities between January 9, 2024 and March 24, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz reminds investors of the upcoming February 3, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) securities between June 4, 2024 and August 8, 2024, inclusive (the “Class Period”).

The Law Offices of Frank R. Cruz announces an investigation of Construction Partners, Inc. (“Construction Partners” or the “Company”) (NASDAQROAD) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Triumph Financial, Inc. (“Triumph” or the “Company”) (NASDAQTFIN) on behalf of investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) on behalf of investors concerning the Company’s possible violations of federal securities laws.